| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alkenylglycerophosphocholine hydrolase activity | 7.18e-06 | 2 | 54 | 2 | GO:0047408 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR8H2 CYSLTR2 OR5AC1 GALR3 GPR35 OR6C4 GPR37L1 OR10A6 CHRM2 OR6K6 GLP2R | 2.01e-05 | 884 | 54 | 11 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR8H2 CYSLTR2 OR5AC1 NRXN3 GALR3 GPR35 OR6C4 GPR37L1 OR10A6 CHRM2 OR6K6 IL6ST GLP2R | 4.84e-05 | 1353 | 54 | 13 | GO:0004888 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 1.43e-04 | 296 | 54 | 6 | GO:0015291 | |
| GeneOntologyMolecularFunction | D-glucose:sodium symporter activity | 1.49e-04 | 7 | 54 | 2 | GO:0005412 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 2.44e-04 | 465 | 54 | 7 | GO:0046873 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 3.89e-04 | 11 | 54 | 2 | GO:0098973 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 4.60e-04 | 133 | 54 | 4 | GO:0008528 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ether bonds | 5.49e-04 | 13 | 54 | 2 | GO:0016801 | |
| GeneOntologyMolecularFunction | ether hydrolase activity | 5.49e-04 | 13 | 54 | 2 | GO:0016803 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 5.58e-04 | 140 | 54 | 4 | GO:0001653 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 9.21e-04 | 758 | 54 | 8 | GO:0015318 | |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 9.51e-04 | 17 | 54 | 2 | GO:0005402 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 1.08e-03 | 167 | 54 | 4 | GO:0015079 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC5A11 SLC9A3 KCNU1 SLC17A3 SLC25A10 SLC35C2 SLC5A9 SVOP KCNH3 KCNH5 | 1.11e-03 | 1180 | 54 | 10 | GO:0022857 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.18e-03 | 171 | 54 | 4 | GO:0015081 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 1.37e-03 | 81 | 54 | 3 | GO:0015370 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.43e-03 | 627 | 54 | 7 | GO:0022890 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 1.76e-03 | 477 | 54 | 6 | GO:0022804 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 1.98e-03 | 664 | 54 | 7 | GO:0008324 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 2.07e-03 | 25 | 54 | 2 | GO:0055056 | |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 2.07e-03 | 25 | 54 | 2 | GO:0015149 | |
| GeneOntologyMolecularFunction | protein kinase A regulatory subunit binding | 2.07e-03 | 25 | 54 | 2 | GO:0034237 | |
| GeneOntologyMolecularFunction | transporter activity | SLC5A11 SLC9A3 KCNU1 SLC17A3 SLC25A10 SLC35C2 SLC5A9 SVOP KCNH3 KCNH5 | 2.14e-03 | 1289 | 54 | 10 | GO:0005215 |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 2.41e-03 | 27 | 54 | 2 | GO:0015145 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 2.78e-03 | 29 | 54 | 2 | GO:0051119 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 3.38e-03 | 32 | 54 | 2 | GO:0099186 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 4.10e-03 | 119 | 54 | 3 | GO:0015294 | |
| GeneOntologyMolecularFunction | odorant binding | 4.92e-03 | 127 | 54 | 3 | GO:0005549 | |
| GeneOntologyMolecularFunction | potassium channel activity | 5.03e-03 | 128 | 54 | 3 | GO:0005267 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 5.29e-03 | 793 | 54 | 7 | GO:0015075 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 5.77e-03 | 42 | 54 | 2 | GO:0098918 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 5.77e-03 | 42 | 54 | 2 | GO:0015144 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 6.08e-03 | 431 | 54 | 5 | GO:0004984 | |
| GeneOntologyMolecularFunction | antiporter activity | 6.19e-03 | 138 | 54 | 3 | GO:0015297 | |
| GeneOntologyMolecularFunction | symporter activity | 7.79e-03 | 150 | 54 | 3 | GO:0015293 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 8.86e-03 | 301 | 54 | 4 | GO:0022853 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 9.73e-03 | 55 | 54 | 2 | GO:0017046 | |
| GeneOntologyMolecularFunction | protein kinase A binding | 1.08e-02 | 58 | 54 | 2 | GO:0051018 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.26e-02 | 334 | 54 | 4 | GO:0022836 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | 1.31e-02 | 1418 | 54 | 9 | GO:0030234 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.31e-02 | 182 | 54 | 3 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.35e-02 | 184 | 54 | 3 | GO:0022832 | |
| Domain | YhhN | 7.90e-06 | 2 | 53 | 2 | PF07947 | |
| Domain | YhhN | 7.90e-06 | 2 | 53 | 2 | IPR012506 | |
| Domain | 7tm_1 | OR8H2 CYSLTR2 GALR3 GPR35 OR6C4 GPR37L1 OR10A6 OR3A4P CHRM2 OR6K6 | 1.74e-05 | 677 | 53 | 10 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR8H2 CYSLTR2 GALR3 GPR35 OR6C4 GPR37L1 OR10A6 OR3A4P CHRM2 OR6K6 | 1.93e-05 | 685 | 53 | 10 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR8H2 CYSLTR2 GALR3 GPR35 OR6C4 GPR37L1 OR10A6 OR3A4P CHRM2 OR6K6 | 2.08e-05 | 691 | 53 | 10 | PS50262 |
| Domain | GPCR_Rhodpsn | OR8H2 CYSLTR2 GALR3 GPR35 OR6C4 GPR37L1 OR10A6 OR3A4P CHRM2 OR6K6 | 2.11e-05 | 692 | 53 | 10 | IPR000276 |
| Domain | Rhs_assc_core | 2.37e-05 | 3 | 53 | 2 | IPR022385 | |
| Domain | DUF1981 | 4.72e-05 | 4 | 53 | 2 | PF09324 | |
| Domain | DCB_dom | 4.72e-05 | 4 | 53 | 2 | IPR032629 | |
| Domain | Tox-GHH_dom | 4.72e-05 | 4 | 53 | 2 | IPR028916 | |
| Domain | TENEURIN_N | 4.72e-05 | 4 | 53 | 2 | PS51361 | |
| Domain | Ten_N | 4.72e-05 | 4 | 53 | 2 | IPR009471 | |
| Domain | Tox-GHH | 4.72e-05 | 4 | 53 | 2 | PF15636 | |
| Domain | Ten_N | 4.72e-05 | 4 | 53 | 2 | PF06484 | |
| Domain | Sec7_N | 4.72e-05 | 4 | 53 | 2 | IPR032691 | |
| Domain | DCB | 4.72e-05 | 4 | 53 | 2 | PF16213 | |
| Domain | Sec7_N | 4.72e-05 | 4 | 53 | 2 | PF12783 | |
| Domain | Sec7_C | 4.72e-05 | 4 | 53 | 2 | IPR015403 | |
| Domain | YD | 7.86e-05 | 5 | 53 | 2 | IPR006530 | |
| Domain | GPCR_Rhodpsn_7TM | 1.01e-04 | 670 | 53 | 9 | IPR017452 | |
| Domain | PAS_9 | 3.50e-04 | 10 | 53 | 2 | PF13426 | |
| Domain | NA_SOLUT_SYMP_1 | 4.27e-04 | 11 | 53 | 2 | PS00456 | |
| Domain | NA_SOLUT_SYMP_2 | 5.12e-04 | 12 | 53 | 2 | PS00457 | |
| Domain | SSF | 5.12e-04 | 12 | 53 | 2 | PF00474 | |
| Domain | Na/solute_symporter | 5.12e-04 | 12 | 53 | 2 | IPR001734 | |
| Domain | NA_SOLUT_SYMP_3 | 5.12e-04 | 12 | 53 | 2 | PS50283 | |
| Domain | NHL | 6.04e-04 | 13 | 53 | 2 | PS51125 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 7.03e-04 | 14 | 53 | 2 | IPR003938 | |
| Domain | Sec7 | 8.10e-04 | 15 | 53 | 2 | PF01369 | |
| Domain | Sec7_alpha_orthog | 8.10e-04 | 15 | 53 | 2 | IPR023394 | |
| Domain | - | 8.10e-04 | 15 | 53 | 2 | 1.10.1000.11 | |
| Domain | Sec7 | 9.24e-04 | 16 | 53 | 2 | SM00222 | |
| Domain | Sec7_dom | 9.24e-04 | 16 | 53 | 2 | IPR000904 | |
| Domain | SEC7 | 9.24e-04 | 16 | 53 | 2 | PS50190 | |
| Domain | CarboxyPept-like_regulatory | 1.05e-03 | 17 | 53 | 2 | IPR008969 | |
| Domain | PAS-assoc_C | 2.10e-03 | 24 | 53 | 2 | IPR000700 | |
| Domain | PAC | 2.46e-03 | 26 | 53 | 2 | SM00086 | |
| Domain | PAC | 2.46e-03 | 26 | 53 | 2 | PS50113 | |
| Domain | PAC | 2.46e-03 | 26 | 53 | 2 | IPR001610 | |
| Domain | CNMP_BINDING_1 | 3.71e-03 | 32 | 53 | 2 | PS00888 | |
| Domain | CNMP_BINDING_2 | 3.71e-03 | 32 | 53 | 2 | PS00889 | |
| Domain | PAS | 3.71e-03 | 32 | 53 | 2 | SM00091 | |
| Domain | Ion_trans_dom | 4.16e-03 | 114 | 53 | 3 | IPR005821 | |
| Domain | Ion_trans | 4.16e-03 | 114 | 53 | 3 | PF00520 | |
| Domain | cNMP | 4.18e-03 | 34 | 53 | 2 | SM00100 | |
| Domain | PAS | 4.18e-03 | 34 | 53 | 2 | IPR000014 | |
| Domain | PAS | 4.18e-03 | 34 | 53 | 2 | PS50112 | |
| Domain | cNMP_binding | 4.18e-03 | 34 | 53 | 2 | PF00027 | |
| Domain | cNMP-bd_dom | 4.43e-03 | 35 | 53 | 2 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 4.43e-03 | 35 | 53 | 2 | PS50042 | |
| Domain | Olfact_rcpt | 5.04e-03 | 393 | 53 | 5 | IPR000725 | |
| Domain | cNMP-bd-like | 5.20e-03 | 38 | 53 | 2 | IPR018490 | |
| Domain | - | 5.47e-03 | 39 | 53 | 2 | 2.120.10.30 | |
| Domain | 6-blade_b-propeller_TolB-like | 7.55e-03 | 46 | 53 | 2 | IPR011042 | |
| Domain | - | 8.20e-03 | 48 | 53 | 2 | 2.60.120.10 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 17360629 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 10716990 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 18203920 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 10212200 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 23918382 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 18417613 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 20100464 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 19332778 | ||
| Pubmed | Specific functions of BIG1 and BIG2 in endomembrane organization. | 7.36e-06 | 3 | 55 | 2 | 20360857 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 18832381 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 16866877 | ||
| Pubmed | Involvement of BIG1 and BIG2 in regulating VEGF expression and angiogenesis. | 7.36e-06 | 3 | 55 | 2 | 31199673 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 18003980 | ||
| Pubmed | Enhancement of β-catenin activity by BIG1 plus BIG2 via Arf activation and cAMP signals. | 7.36e-06 | 3 | 55 | 2 | 27162341 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 23386609 | ||
| Pubmed | 8.01e-06 | 650 | 55 | 8 | 38777146 | ||
| Pubmed | 1.01e-05 | 313 | 55 | 6 | 20800603 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 12571360 | ||
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 1.47e-05 | 4 | 55 | 2 | 10225957 | |
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 22084092 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 11013081 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 24891332 | ||
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 1.47e-05 | 4 | 55 | 2 | 12000766 | |
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 12606707 | ||
| Pubmed | 5.13e-05 | 7 | 55 | 2 | 10625539 | ||
| Pubmed | 5.13e-05 | 7 | 55 | 2 | 22116950 | ||
| Pubmed | 5.13e-05 | 7 | 55 | 2 | 12915301 | ||
| Pubmed | 5.45e-05 | 257 | 55 | 5 | 16335952 | ||
| Pubmed | 5.78e-05 | 47 | 55 | 3 | 15172686 | ||
| Pubmed | 6.83e-05 | 8 | 55 | 2 | 10331952 | ||
| Pubmed | 6.83e-05 | 8 | 55 | 2 | 20162743 | ||
| Pubmed | Bimodal regulation of an Elk subfamily K+ channel by phosphatidylinositol 4,5-bisphosphate. | 1.10e-04 | 10 | 55 | 2 | 26503718 | |
| Pubmed | 1.10e-04 | 10 | 55 | 2 | 20923837 | ||
| Pubmed | 1.10e-04 | 10 | 55 | 2 | 38713721 | ||
| Pubmed | 1.34e-04 | 11 | 55 | 2 | 20570916 | ||
| Pubmed | 1.34e-04 | 11 | 55 | 2 | 19890391 | ||
| Pubmed | 1.52e-04 | 510 | 55 | 6 | 16712791 | ||
| Pubmed | 1.98e-04 | 71 | 55 | 3 | 12754519 | ||
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | 2.05e-04 | 183 | 55 | 4 | 31932471 | |
| Pubmed | 2.09e-04 | 541 | 55 | 6 | 14983052 | ||
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 2.54e-04 | 15 | 55 | 2 | 16824795 | |
| Pubmed | 3.70e-04 | 18 | 55 | 2 | 31588230 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 4.12e-04 | 91 | 55 | 3 | 28558017 | |
| Pubmed | A crucial role for Arf6 in the response of commissural axons to Slit. | 4.13e-04 | 19 | 55 | 2 | 30674481 | |
| Pubmed | 4.50e-04 | 405 | 55 | 5 | 38187761 | ||
| Pubmed | CAMK2D serves as a molecular scaffold for RNF8-MAD2 complex to induce mitotic checkpoint in glioma. | 4.53e-04 | 94 | 55 | 3 | 37468549 | |
| Pubmed | Cbln1 regulates axon growth and guidance in multiple neural regions. | 5.56e-04 | 22 | 55 | 2 | 36395107 | |
| Pubmed | 7.20e-04 | 25 | 55 | 2 | 29379870 | ||
| Pubmed | 7.28e-04 | 952 | 55 | 7 | 38569033 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | 7.98e-04 | 697 | 55 | 6 | 28298427 | |
| Pubmed | Little skate genome provides insights into genetic programs essential for limb-based locomotion. | 8.40e-04 | 27 | 55 | 2 | 36288084 | |
| Pubmed | 8.40e-04 | 27 | 55 | 2 | 25133637 | ||
| Pubmed | Modulation of the combinatorial code of odorant receptor response patterns in odorant mixtures. | 8.40e-04 | 27 | 55 | 2 | 32061665 | |
| Pubmed | 9.04e-04 | 28 | 55 | 2 | 32801337 | ||
| Pubmed | 1.04e-03 | 30 | 55 | 2 | 19936222 | ||
| Pubmed | Tangential Intrahypothalamic Migration of the Mouse Ventral Premamillary Nucleus and Fgf8 Signaling. | 1.11e-03 | 31 | 55 | 2 | 34095148 | |
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | 1.15e-03 | 499 | 55 | 5 | 22810586 | |
| Pubmed | Newly identified loci that influence lipid concentrations and risk of coronary artery disease. | 1.41e-03 | 35 | 55 | 2 | 18193043 | |
| Pubmed | A probabilistic classifier for olfactory receptor pseudogenes. | 1.41e-03 | 35 | 55 | 2 | 16939646 | |
| Pubmed | 1.53e-03 | 143 | 55 | 3 | 22516433 | ||
| Interaction | KCNH4 interactions | 1.64e-08 | 12 | 50 | 4 | int:KCNH4 | |
| Interaction | UPK2 interactions | 2.66e-05 | 142 | 50 | 5 | int:UPK2 | |
| Cytoband | 12q24.11 | 8.65e-06 | 33 | 55 | 3 | 12q24.11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q24 | 1.56e-03 | 415 | 55 | 4 | chr12q24 | |
| Cytoband | 5q11.2 | 1.80e-03 | 52 | 55 | 2 | 5q11.2 | |
| Cytoband | 2q21.1 | 2.23e-03 | 58 | 55 | 2 | 2q21.1 | |
| GeneFamily | Solute carriers | 1.86e-04 | 395 | 39 | 6 | 752 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 3.48e-04 | 13 | 39 | 2 | 685 | |
| GeneFamily | Potassium voltage-gated channels | 3.36e-03 | 40 | 39 | 2 | 274 | |
| GeneFamily | Olfactory receptors, family 6 | 5.41e-03 | 51 | 39 | 2 | 153 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 1.23e-02 | 78 | 39 | 2 | 262 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 158 | 55 | 5 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 158 | 55 | 5 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 3.46e-06 | 187 | 55 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-06 | 193 | 55 | 5 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-06 | 193 | 55 | 5 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.45e-06 | 197 | 55 | 5 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | Control-PLT_5|World / Disease Group and Platelet Clusters | 1.79e-05 | 126 | 55 | 4 | 4ba753c4e83eb1d41964edfa22135e047f06c481 | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-05 | 139 | 55 | 4 | 82bf5ba69a907fbd9b4e2b2dd1dd27b8c4c75f25 | |
| ToppCell | facs-Liver-Hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-05 | 139 | 55 | 4 | fc4b39ac9a10cf0acacfebbc4295edf324d930d5 | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-05 | 139 | 55 | 4 | 4ddfbc36a0560fb70594627178bff652ab1ea3e9 | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-05 | 139 | 55 | 4 | fc9ac09c2106e88104a52575832d71d17765eec8 | |
| ToppCell | TCGA-Bile_Duct|World / Sample_Type by Project: Shred V9 | 2.71e-05 | 140 | 55 | 4 | ca8a0ccbc2f501b759864fe9bb06dc8b44b6b31f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.39e-05 | 167 | 55 | 4 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.05e-05 | 179 | 55 | 4 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-05 | 183 | 55 | 4 | 6c4a09c02e30e1f24dde39f8cb8c5b453826ee2e | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 7.85e-05 | 184 | 55 | 4 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.35e-05 | 187 | 55 | 4 | 8e8f1f2a78ac5f13a414fd448af7d7ff1ea86f0f | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 8.70e-05 | 189 | 55 | 4 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-05 | 191 | 55 | 4 | b94e66ac71e73f46b0323d424e7b8b906751d584 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.06e-05 | 191 | 55 | 4 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 9.06e-05 | 191 | 55 | 4 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 9.06e-05 | 191 | 55 | 4 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 9.25e-05 | 192 | 55 | 4 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 9.43e-05 | 193 | 55 | 4 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.43e-05 | 193 | 55 | 4 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.43e-05 | 193 | 55 | 4 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.43e-05 | 193 | 55 | 4 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 9.43e-05 | 193 | 55 | 4 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.62e-05 | 194 | 55 | 4 | 715e02e5f3250b1bfdc26b7dfd656ba4e705ea84 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.82e-05 | 195 | 55 | 4 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.82e-05 | 195 | 55 | 4 | 26a3a5daf389606ef1ebb35533f12e60853b3a12 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.82e-05 | 195 | 55 | 4 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 197 | 55 | 4 | 6668f0da54f3bf96769275e668cd57e00b8a5ef9 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 197 | 55 | 4 | 7c275a2ac24a9a4f83fceda93a067e754837102f | |
| ToppCell | IPF|World / Disease state, Lineage and Cell class | 1.04e-04 | 198 | 55 | 4 | 7f8734729194caccab8ec98e6c1a00ff5c3655af | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-04 | 199 | 55 | 4 | f26c20f5d7470e90eaa79613d0b87bd4865585a8 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.08e-04 | 200 | 55 | 4 | 07641f476cb1a131c2a50258b88cc13bb38c8379 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.08e-04 | 200 | 55 | 4 | 343fa6ba1f52d816d2e41466f674ff8360aecd81 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.08e-04 | 200 | 55 | 4 | d0c00cdd52c2e001aec9b935f4e981ba77d0386a | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Chat-Inhibitory_Neuron.Gad1Gad2-Chat-Slc17a8.Chat_(cholinergic_interneuron)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.14e-04 | 76 | 55 | 3 | 3073a8ace46ad18bddd22ec8f3a1b59ee2fd989d | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Chat-Inhibitory_Neuron.Gad1Gad2-Chat-Slc17a8.Chat_(cholinergic_interneuron)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.14e-04 | 76 | 55 | 3 | 3f5865b9cb6648b88eb873018e513c5efb457ae5 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Chat|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.14e-04 | 76 | 55 | 3 | 041a8984b3ae4bb03ae6db8234c1333ac73098fa | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.54e-04 | 84 | 55 | 3 | 9417fffe0ba79f5851920258dcd0f6c09218be13 | |
| Disease | tyrosine-protein phosphatase non-receptor type 7 measurement | 3.05e-06 | 2 | 52 | 2 | EFO_0802173 | |
| Disease | AP-4 complex subunit mu-1 measurement | 3.04e-05 | 5 | 52 | 2 | EFO_0801385 | |
| Disease | annexin A2 measurement | 6.36e-05 | 7 | 52 | 2 | EFO_0008027 | |
| Disease | mannose measurement | 8.47e-05 | 8 | 52 | 2 | EFO_0006958 | |
| Disease | sialic acid-binding Ig-like lectin 12 measurement | 8.47e-05 | 8 | 52 | 2 | EFO_0802066 | |
| Disease | ovarian reserve | 1.99e-04 | 12 | 52 | 2 | EFO_0004770 | |
| Disease | triglyceride measurement, body mass index | 5.11e-04 | 19 | 52 | 2 | EFO_0004340, EFO_0004530 | |
| Disease | triglyceride measurement, body fat percentage | 6.26e-04 | 21 | 52 | 2 | EFO_0004530, EFO_0007800 | |
| Disease | taurine measurement | 9.64e-04 | 26 | 52 | 2 | EFO_0010536 | |
| Disease | L lactate dehydrogenase measurement | 9.64e-04 | 26 | 52 | 2 | EFO_0004808 | |
| Disease | Drug habituation | 1.11e-03 | 115 | 52 | 3 | C0013170 | |
| Disease | Drug abuse | 1.11e-03 | 115 | 52 | 3 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.11e-03 | 115 | 52 | 3 | C4316881 | |
| Disease | Substance-Related Disorders | 1.11e-03 | 115 | 52 | 3 | C0236969 | |
| Disease | Drug Use Disorders | 1.11e-03 | 115 | 52 | 3 | C0013222 | |
| Disease | Drug Dependence | 1.11e-03 | 115 | 52 | 3 | C1510472 | |
| Disease | Substance Dependence | 1.11e-03 | 115 | 52 | 3 | C0038580 | |
| Disease | Substance Use Disorders | 1.11e-03 | 115 | 52 | 3 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.11e-03 | 115 | 52 | 3 | C0029231 | |
| Disease | Substance abuse problem | 1.14e-03 | 116 | 52 | 3 | C0740858 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.21e-03 | 264 | 52 | 4 | EFO_0008317, EFO_0020944 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALYYTTMQTLTKQDT | 41 | Q9H3F6 | |
| AMYVAIQAVLSLYTS | 131 | Q9BYX7 | |
| ADTAYVLAYSIIMLT | 821 | Q9Y6D6 | |
| ADTAYVLAYSIIMLT | 766 | Q9Y6D5 | |
| IIGVFSMNLYTLYTV | 71 | P08172 | |
| QMTYSLTRFAIYETV | 71 | Q9UBX3 | |
| VEMTSYVLLAYLTAQ | 1206 | P01023 | |
| GTCSYINYVITMTTL | 111 | Q6ZS30 | |
| MTVYALVVVSYFLIT | 31 | Q9NRP0 | |
| RYSQYSAVVLTLLMA | 351 | Q9ULD8 | |
| AMYVAIQAVLSLYTS | 831 | A5A3E0 | |
| TLMVSLFTISASYVF | 206 | Q8N162 | |
| LVSTMVVYIPTYISS | 231 | O00476 | |
| TLYSYKVQSTITSRM | 71 | P19823 | |
| AEFSNVMIIYTSIVY | 606 | Q9UDY8 | |
| DSLYVSSLYFTMTSL | 416 | Q8NCM2 | |
| YLAICQSLTYSSRMS | 126 | P47883 | |
| ILTTTGYTQEDYTML | 361 | Q9Y4C0 | |
| ISYFESIYLVMATTS | 261 | A8MYU2 | |
| YLMENVTIYLSATSD | 911 | P56199 | |
| MVTLVLVTLSYTYII | 206 | Q8NGE1 | |
| YLTNRYMSISLVTAI | 96 | Q9HC97 | |
| YSYISLTAMAIQSSP | 16 | Q99853 | |
| YQRLYSESILTTMVQ | 71 | Q14397 | |
| IQVFTFMTLIVSYSY | 206 | P0C628 | |
| FMTLIVSYSYILSAI | 211 | P0C628 | |
| LIYLTMYASSFTLAA | 101 | O60755 | |
| EYTLSSLTSDTLYMV | 576 | P40189 | |
| STLQLMYTVGYSFSL | 176 | O95838 | |
| SSYSAYAIMLLALVV | 126 | O60883 | |
| SVTTSYNLARLYEAM | 496 | Q6PD62 | |
| MTSILLTYVYFVLSL | 31 | Q9BW60 | |
| TDRIYLTLTQALSMY | 1811 | Q8IVF4 | |
| TQLYTMTSTLEYKTT | 196 | Q13740 | |
| VLIFASYMTTVIEYV | 321 | Q9BTV7 | |
| TMTYLTRAVASYLQE | 1211 | P46019 | |
| TSVTLFYGTASMTYL | 246 | Q8NH74 | |
| LVTALYSLYMFTTTQ | 401 | P03905 | |
| SVAVMYLRFSATYSV | 281 | Q8NGW6 | |
| VMLESSVYLTLAVYS | 481 | Q8N4V2 | |
| LTYIYASVRTLLMEN | 751 | Q9P0V3 | |
| FIISYLSYLTSEMLS | 291 | P48764 | |
| QVYMSVLSLILYIFT | 151 | Q2M3M2 | |
| YLYFSMILSTVTLIT | 521 | Q8WWX8 | |
| YYDINQIITTAVMTL | 2136 | Q9NT68 | |
| LLQSSVITVYTMYLT | 261 | Q9NRX5 | |
| LYSVMTLVSTYLVAF | 61 | Q9UNL2 | |
| VTSTYSKMSLQLYQV | 451 | Q13131 | |
| NMYSSIYFLTVLSVV | 121 | Q9NS75 | |
| STYYVAQMLVALSAV | 211 | Q8N2M4 | |
| LYVTVSLYTMTKSSA | 106 | Q9NQQ7 | |
| IYYDINQIITTAVMT | 2126 | Q6N022 | |
| VIMTTYYAAQLLITL | 201 | Q8N661 | |
| QVLSTVLSMYVVYST | 656 | O95427 | |
| VLSMYVVYSTQSSLL | 661 | O95427 | |
| VLMDIQASTVVTYVY | 151 | Q9UBQ0 | |
| YAYSISTIIKTTMNL | 446 | Q2M389 | |
| QTSRTTTAVYMLYLL | 426 | P59046 |